Novo Nordisk filed suit against Eli Lilly in 2026 alleging misleading advertising in the obesity drug market, marking the first time major pharmaceutical manufacturers have taken their GLP-1 marketing battle to court . The lawsuit targets promotional claims around Lilly's obesity medications, a conf

A federal judge's dismissal of UnitedHealth Group's defamation lawsuit against The Guardian in 2026 marks one of the most visible failures of a litigation-as-reputation-management strategy in recent healthcare history , and it leaves the nation's largest health insurer in a worse public position tha

Xenco Medical's XenVision demonstration at SIGGRAPH 2026 marks the moment when AI visualization technology stopped being a future-forward experiment and became a present-tense competitive weapon for healthcare marketers. The medical device manufacturer chose the computer graphics industry's flagship

On July 1, 2026, the FDA issued a supplemental approval for Casgevy (exagamglogene autotemcel), developed by Vertex Pharmaceuticals, expanding its indicated use to patients aged 2 years and older with sickle cell disease (SCD) accompanied by recurrent vaso-occlusive crises (VOCs) or transfusion-depe

Washington state began distributing benefits July 1, 2026, through WA Cares—the nation's first state-operated long-term care insurance program funded by a 0.58% payroll tax. About 3.7 million workers participated last year, paying roughly $500 annually for a lifetime benefit of $36,500 after 10 year

The FDA's approval covers generic baloxavir marboxil tablets for patients five years of age and older, applicable to both treatment of acute uncomplicated influenza (when symptoms begin within 48 hours) and post-exposure prophylaxis following known exposure to an infected individual [1]. The drug's

Health systems spent the last decade connecting genomic data to EHRs. The next competitive battlefield is making that data discoverable when patients ask AI where to go for precision medicine. The organizations that close the "exome gap" — the chasm between having genomic capabilities and being reco

Albany Med Health System's exploration of an affiliation with Ellis Medicine represents the continuation of a merger trend that reshrites the rules for patient acquisition across regional markets. For healthcare marketers, these transactions create immediate headwinds: duplicate service lines, overl

Healthcare systems face a collision: hospital cash reserves are under scrutiny at the exact moment patient acquisition channels are evaporating. Days cash on hand—the number of days a health system can operate using only its cash reserves—has become a critical metric as 35 major health systems face

The Centers for Medicare & Medicaid Services has finalized a federal framework enabling states to impose work requirements on Medicaid enrollees , a structural shift that carries direct consequences for patient volume, service-line revenue, and community health marketing strategies at hospitals and